Valeant Pharmaceuticals International Inc. said it appointed Sam Eldessouky as chief accounting officer last Wednesday, according to a Securities and Exchange Commission filing late Tuesday. Eldessouky took over the duties from Robert Rosiello, who will continue as chief financial officer, the company said. Valeant shares fell 1.1% to $21.40 after hours.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News